InvestorsHub Logo
Followers 24
Posts 2347
Boards Moderated 0
Alias Born 06/03/2012

Re: BigE1960 post# 96887

Monday, 01/11/2021 11:28:00 AM

Monday, January 11, 2021 11:28:00 AM

Post# of 104531
True, but "comparing" the accuracy of their new and improved antibody test to the accuracy of the old lateral flow antigen tests is kink of apples and oranges since the two types of tests have different purposes. Just being critical.

The new immunity test, entirely developed and manufactured in the UK, claims to be the only ultra-rapid test in the world with near-100% accuracy. The whole development process, from its conception to full-scale manufacture, has been achieved by experts at Bio-Diagnostics laboratories under UK regulations.

The shortcomings inherent to old ‘lateral flow’ tests have been apparent to the UK authorities for months. In December 2020, the British Medical Journal reported that the test kits most widely used in UK universities, schools and care homes detected only 48% of COVID-19 infections in asymptomatic people.

A lateral flow tested by US firm Innova failed to detect three-in-10 cases with the highest viral loads in the key pilot scheme in Liverpool. The UK Government has spent £700m buying the Innova kits, which have until now ‘formed the lynchpin of its mass testing strategy’, reports the BMJ.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.